Press Coverage

All press coverage

Royalty Pharma and Biohaven Announce Funding Agreement Totaling up to $450 Million (Royalty Pharma)

Cooley acted as legal advisor to Biohaven on the transaction. Goodwin Procter, Jones Day and Maiwald acted as legal advisors to Royalty Pharma.

This text is a press release from Royalty Pharma.